Background-The index of microcirculatory resistance (IMR) is a quantitative and specific index for coronary microcirculation. However, the distribution and determinants of IMR have not been fully investigated in patients with ischemic heart disease (IHD). Methods and Results-Consecutive patients who underwent elective measurement of both fractional flow reserve (FFR) and IMR were enrolled from 8 centers in 5 countries. Patients with acute myocardial infarction were excluded. 
Lee et al IMR in Patients With Ischemic Heart Disease
T he coronary microcirculation is one of the major components of the coronary vascular system and an important contributor to the development of ischemic heart disease (IHD). However, limitations in the methods available to visualize or evaluate the microcirculatory system have been an obstacle to the diagnosis and treatment of microvascular disease. The index of microcirculatory resistance (IMR) is a pressure-temperature-derived parameter for quantifying microcirculatory resistance. 1 Because distal coronary pressure is used in the calculation of IMR, this index can be used to interrogate selectively the microcirculation of vessels with a coronary stenosis, in contrast to coronary flow reserve, which is a combined assessment of the macro-and microcirculation. Previous studies have shown that IMR is independent of the severity of epicardial coronary stenosis as determined by angiographic or functional (fractional flow reserve [FFR] ) criteria so long as the influence of collateral flow is taken into account. 2, 3 IMR is also relatively independent of hemodynamic conditions, such as blood pressure and heart rate. 4 Recent clinical studies have shown that IMR is useful for the risk stratification in patients with acute myocardial infarction (MI). [5] [6] [7] However, in the setting of IHD other than MI, the distribution and determinants of abnormal IMR remain to be clearly identified. Therefore, we sought to investigate the clinical relevance of microvascular assessment using IMR and the relative contribution of macro-and microvascular disease in non-MI patients enrolled from an international multicenter IMR registry.
Methods

Patient Population
From April 2009 to September 2013, patients underwent FFR and IMR measurements and, with available clinical and angiographic information, were registered from 8 hospitals from 5 countries (South Korea, United Kingdom, Spain, USA, and Australia). The investigators were asked to provide the data of eligible patients, and those enrolled in other study protocols or those who underwent FFR and IMR measurements were both included in this study. The operators involved in this study used FFR and IMR in their daily clinical practice. Patients with acute MI with cardiac enzyme elevation were excluded. All patients underwent preinterventional measurement of FFR and IMR, and the postinterventional data were excluded from the analysis. Institutional Review Board approval was obtained with regard to current regulations, and the study protocol was in accordance with the Declaration of Helsinki (clinicaltrials.gov identifier, NCT02186093).
Coronary Angiography and Coronary Physiological Measurements
Coronary angiography was performed by standard techniques. Angiographic views were obtained after the administration of intracoronary nitrate (100 or 200 μg). Quantitative coronary angiography was performed at each participating center using a contour-detection quantitative coronary angiography system and the guiding catheter tip as a scaling device. Percent diameter stenosis, minimum lumen diameter, reference vessel size, and lesion length were measured.
All coronary physiological measurements were obtained as previously described. [7] [8] [9] In brief, a 5-7F guiding catheter without side holes was used to engage the coronary artery, and a pressure-temperature sensor guidewire (St Jude Medical, St Paul, MN) was used for FFR and IMR measurement. The pressure sensor was positioned at the distal segment of the target vessel, and intracoronary nitrate (100 or 200 μg) was administered before each physiological measurement. To derive resting mean transit time (T mn ), a thermodilution curve was obtained by 3 injections of 3-4 mL of room temperature saline. Hyperemia was induced by intravenous infusion of adenosine (140 μg/kg/min) through a central or peripheral vein. Hyperemic proximal aortic pressure (P a ), distal arterial pressure (P d ), and hyperemic T mn were obtained during sustained hyperemia. FFR was calculated as mean P d /P a during hyperemia and apparent IMR (IMR app ) as P d ×T mn during hyperemia. All IMR values were also corrected by Yong's formula (IMR corr =P a ×T mn ×([1.35×P d /P a ]−0.32)) to adjust for the influence of collateral flow. 9 At the end of the study, the guidewire was pulled back to the guiding catheter, and the presence of pressure drift was assessed.
Cut-Off Values for Physiological Indices
Because the distribution of IMR corr was significantly different among the 3 epicardial coronary arteries, 75th percentile values in each of epicardial coronary arteries were used to define an elevated IMR corr . Patients with at least 1 elevated IMR corr were categorized as having high microvascular resistance. Ischemic FFR value was defined as FFR ≤0.80. All patients were classified according to the cut-off values of FFR and IMR corr to explore the relative contributions of macrovascular and microvascular disease.
Statistical Analysis
Categorical variables are presented as numbers and relative frequencies (percentages), and continuous variables as means and standard deviations or median with interquartile range (first, third quartiles) according to their distribution and homogeneity in their variances, which was checked by the Kolmogorov-Smirov test. Data were analyzed on a per-patient basis for clinical characteristics and classification according to FFR and IMR corr and on a per-vessel basis for the rest of analysis.
For per-vessel analysis, including comparison of IMR app or IMR corr values according to the target vessels or comparison of FFR,
WHAT IS KNOWN
• Fractional flow reserve-guided decision-making for patients with epicardial coronary stenosis is a wellvalidated approach.
• The index of microcirculatory resistance (IMR) is a quantitative and specific index for microcirculation. However, the distribution and determinants of IMR have not been fully investigated in patients with stable coronary artery disease.
WHAT THE STUDY ADDS
• In 1096 patients with 1452 vessels who underwent invasive coronary physiological assessment, fractional flow reserve and IMR showed no categorical agreement, and the presence of microvascular disease was suspected to be a contributor for the myocardial ischemia in a significant portion of patients (17% of the population studied).
• The predictors of high IMR (previous myocardial infarction, right coronary artery, female, and obesity) and low fractional flow reserve (angiographic percent diameter stenosis, left anterior descending artery, male, and age) were substantially different.
• The integration of IMR into fractional flow reserve measurement can provide additional insights regarding the relative contribution of macro-and microvascular disease in patients with ischemic heart disease.
IMR app , or IMR corr values according to the clinical diagnosis, the generalized estimating equation with exchangeable correlation structure was used to adjust for intrasubject variability among vessels from the same patients. Estimated mean and 95% confidence interval (CI) were presented as summary statistics. No post hoc adjustment was performed. A model to determine the predictors of abnormal FFR or IMR corr was constructed. The included covariates were variables having clinical importance or those with a single variable P value <0.1, as follows: sex, hypertension, diabetes mellitus, hypercholesterolemia, family history of coronary artery disease (CAD), obesity defined as body mass index ≥25 kg/m 2 for the Asian population or ≥30 kg/m 2 for the Western population, current smoking, acute coronary syndrome, history of MI or percutaneous coronary intervention, target vessel, diameter stenosis ≥50%, lesion length, reference vessel diameter, and age. The discriminant functions of each model were presented with c-index and 95% CI. The statistical package SPSS, version 18.0 (SPSS Inc., Chicago, IL), and R programming language, version 3.1.3 (R Foundation for Statistical Computing), were used for statistical analyses.
Results
Baseline Characteristics
The enrolled population was 1096 patients with 1452 vessels. Table 1 and Table 2 show their baseline clinical characteristics and the details of the coronary stenoses studied. Six hundred and thirty-five patients (58%) and 364 patients (42%) were from Asian and Western populations, respectively. 51% of patients presented as stable angina and 10% as asymptomatic CAD with evidence of myocardial ischemia in noninvasive tests. More than half of the vessels studied were left anterior descending artery (LAD), and most stenoses had an intermediate degree of severity (mean diameter stenosis, 40.5±17.3%). The reference diameter of right coronary artery (RCA) was larger than LAD or left circumflex artery (LCX; 3.32±0.59 mm in RCA, 2.90±0.55 mm in LAD, or 2.89±0.61 mm in LCX, P<0.001). Figure 1 shows the distribution of measured FFR and IMR values. The mean FFR was 0.84±0.14, and median IMR app and IMR corr were 17.0 U (13.0 U, 23.5 U) and 16.6 U (12.4 U, 23.0 U), respectively ( 
Distribution of Physiological Indices
Populations Distribution According to the FFR and IMR Values
The categorical agreement of FFR and IMR corr was low (kappa value=−0.04, P=0.10; Figure 3A ). 55% of patients showed discordant results. Figure 3B shows the categorization of patients according to the cut-off values of FFR and IMR corr . Overall, 17% of patients had stenoses with nonischemic FFR values but abnormally high microvascular resistance, whereas 8% of patients had both stenoses with ischemic FFR values and abnormally high microvascular resistance. (Table 3 ). The dichotomous data of IMR corr in these cohorts are presented in Table I 
Discussion
This study provides new insights into the overall characteristics of IMR in patients with coronary atherosclerosis without MI. The distinct value of these observations is that they are derived from a large, multiethnic patient population. The main findings of the study are (1) FFR and IMR corr showed no categorical agreement, and the presence of microvascular disease was suspected to be a contributor for the myocardial ischemia in a significant portion of patients (17% of the population studied); (2) more than one quarter (26%) of vessels with functionally nonsignificant stenoses (FFR >0.80) had abnormally high IMR corr values; and (3) the predictors of high IMR corr or ischemic FFR were substantially different. These findings suggest the need to integrate IMR with FFR when evaluating patients with CAD.
Relative Contribution of Macro-and Microvascular Disease to IHD
Currently, FFR-guided decision-making for epicardial coronary stenosis has been a well-validated approach to avoid unnecessary stent implantation and to enhance patient clinical outcomes. [10] [11] [12] However, epicardial coronary stenosis is one of the components in the coronary circulatory system; therefore, the presence of epicardial stenosis is not a sole cause of IHD. Furthermore, lesions with the same degree of stenosis may have different FFR values, according to the microvascular status. In our study, among patients with nonischemic FFR values (>0.80), 26% had high IMR corr . These patients could potentially experience myocardial ischemia secondary to microvascular disease. 13 A similar percentage of microvascular dysfunction based on IMR measurement was seen in a recent study evaluating patients with chest pain and nonobstructive coronary disease.
14 This could at least partly explain why some patients with nonischemic FFR values continue to report symptoms consistent with angina. In the FAME II registry population, (FFR >0.80 and deferral of percutaneous coronary intervention), ≈15% of patients had persistent Canadian Cardiovascular Society (CCS) class II-IV angina at 2-years follow-up. Additional evidence supporting the potential prognostic relevance of documenting coexisting coronary circulatory abnormalities in patients with nonsignificant FFR values comes from recently published research on the long-term follow-up of patients interrogated with FFR and concomitant 16 In our population, 7.5% of cases had both ischemic FFR values and high IMR corr values. However, the mean FFR value in our study population was higher (0.84±0.14) and IMR corr were lower (median 16. . IMR cut-off values in these studies are based on frequency distributions, and the FFR values will also influence IMR corr values (through Yong's correction). Accordingly, the observed differences between these 2 studies may have been influenced in part by their different study populations.
Determinants of High IMR
In the current study, multivariate generalized estimating equation model showed that previous MI, RCA, female sex, and obesity were significantly associated with high IMR corr . The pathophysiologic mechanisms of primary microvascular disease have not been well defined. Nonetheless, recent studies report sex differences in the presentation, diagnosis, management, and pathophysiological mechanisms of CAD. 17 So-called cardiac Syndrome X, which is the presence of myocardial ischemia without significant epicardial coronary stenosis, is more common in females, 18 and recent reports suggest that microvascular dysfunction might be the main pathophysiological mechanism in this condition. [18] [19] [20] Luo et al presented that the patients with cardiac syndrome X (female 72% of the patients) had significantly higher IMR compared with ageand sex-matched control patients (33.1±7.9 versus 18.8±5.6, P<0.01). 19 Further reports suggest that estrogen deficiency, which is commonly observed in menopausal females, might be related to coronary microvascular disease. 18, 21 Our finding that female sex is a predictor of high IMR corr is consistent with the previous studies which reported a higher prevalence of cardiac syndrome X in female patients, especially with postmenopausal status, and suggest microvascular disease as a potential mechanism of IHD in these patients.
Interestingly, obesity was also a determinant for high IMR corr . There is evidence that obesity is a contributor to coronary microvascular disease. 22 Expansion of adipose tissue leads to tissue hypoxia and results in an increased production of various cytokines (leptin, resistin, tumor necrosis factor, and interleukin-6). These secreted adipokines and proinflammatory cytokines can induce oxidative stress, which leads to reduced availability of nitric oxide and limits vasodilatory capacity. However, Echavarria-Pinto et al reported a relationship between obesity (defined as body mass index ≥30 kg/ m 2 ), lower IMR corr values, and more frequent hypotensive responses to intravenous adenosine infusion in 79 patients with intermediate stenosis. 23 Likewise, there have been controversies whether common cardiovascular risk factors which have been known to cause macrovascular disease are also risk factors for primary microvascular disease. 24 In our results, conventional risk factors of macrovascular disease, as well as stenosis severity of epicardial coronary stenosis, were not associated with high IMR.
These results, along with the lack of correlation and categorical agreement between FFR and IMR, suggest the hypothesis that macro-and microvascular disease are different disease processes with different predisposing factors. 1, 24, 25 In addition, these results reinforce the clinical relevance of IMR measurement in current FFR-guided strategy to enhance patient stratification and to clarify the relative contribution of macro-and microvascular disease as a cause of IHD.
Assessment for Microvascular Disease With IMR
The major obstacle to integrate the concept of IMR into the clinical fields has been a lack of well-validated normal ranges, especially for IHD patients without MI. Most of the previous studies evaluated IMR in patients with acute MI. [5] [6] [7] Recently, Fearon et al reported that in patients who underwent primary percutaneous coronary intervention for acute MI and had immediate post-percutaneous coronary intervention measurement of IMR and those with IMR >40 U had significantly higher 1-year rates of death or hospitalization with heart failure than patients with an IMR <40 U. 5 Previous studies suggested that the upper normal value of IMR is between 25 and 29 U. Melikian et al found that IMR values in a small normal control group without evidence of atherosclerosis were lower than 25 U. 26 In patients with intermediate coronary stenoses, Echavarria-Pinto et al derived an IMR corr cut-off value of 29 U based on the 75th percentile of observed IMR corr values. 16 In their study, 91 arteries in 78 patients were interrogated and 31% of patients were presented as post-MI. However, there have been no large studies exploring the real-world distribution of IMR among IHD patients without MI. In the current study, we evaluated 1096 patients with 1452 vessels who underwent invasive coronary physiological assessment. From the results, the IMR corr showed median of 16.6 U (12.4 U, 23.0 U), and >75th percentile cut-off in all lesions was 23 U. It is reassuring that the upper limit of the normal value for IMR is within the same range as previous studies of patients with stable IHD. Nonetheless, it should be noticed that most patients enrolled to this registry had undergone FFR and IMR measurement with clinical indications of invasive coronary angiography and FFR measurement. Therefore, the distribution of IMR values in a healthy population, without any symptoms and clinical indications of invasive coronary angiography, might be different.
In addition, the distribution of IMR corr was different among the 3 major coronary arteries, even though the observed differences were relatively small. As the IMR is the product of myocardial flow (1/T mn ) and distal arterial pressure (P d ), it can be influenced by blood flow pattern, flow rate, vessel geometry, and the myocardial mass that is supplied by the specific target vessel. 27, 28 This influence is supported by the work of Murai 
Limitations
First, because we excluded patients with elevated cardiac enzyme, our findings cannot be applied to patients with acute MI. However, the main purpose of this study was to explore the practical value of IMR in assessing CAD patients without MI. Second, we did not use the wedge pressure to adjust the IMR values because it was not practical to measure wedge pressure in patients with intermediate stenosis. However, corrected IMR values by Yong's formula 9 were used to minimize the influence of collateral flow, and the differences between the uncorrected (IMR app ) and corrected IMR (IMR corr ) values were small. Third, the results of noninvasive test were not available in our study. Although patients with high FFR and high IMR might have myocardial ischemia because of microvascular disease, this relationship was not confirmed by noninvasive tests. Fourth, a comparative analysis regarding clinical outcomes according to the different IMR level was not performed. The prognostic impact of high IMR corr in stable IHD population and the optimal cut-off value to discriminate patients at higher risk of future events need further investigation. Fifth, although only experienced operators participated in our study, the reproducibility and variability of IMR measurements among the operators were not tested. Sixth, although multivariate model for predictor of high IMR showed clinically relevant results, the c-index of the model was within borderline range. Seventh, the roles of endothelial dysfunction or coronary vasospasm were not assessed in our study. Finally, the data regarding quantitative measures of angina symptom status, for example, Seattle Angina Questionnaire, were not available in this study.
Conclusions
IMR showed no correlation with FFR and angiographic lesion severity, and the predictors of high IMR value were different from those for ischemic FFR value. Therefore, integration of IMR into FFR measurement may provide additional insights regarding the relative contribution of macro-and microvascular disease in patients with IHD. 
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